{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:33:09Z","timestamp":1793295189454,"version":"4.5.0"},"reference-count":28,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":935,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Pulmonol."],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1002\/ppul.22755","type":"journal-article","created":{"date-parts":[[2013,2,8]],"date-time":"2013-02-08T15:35:32Z","timestamp":1360337732000},"page":"372-376","source":"Crossref","is-referenced-by-count":22,"title":["Moxifloxacin for the treatment of pulmonary tuberculosis in children: A single center experience"],"prefix":"10.1002","volume":"49","author":[{"given":"Silvia","family":"Garazzino","sequence":"first","affiliation":[{"name":"Department of Pediatrics; Infectious Diseases Unit; University of Turin; Regina Margherita Children's Hospital; Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Scolfaro","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Infectious Diseases Unit; University of Turin; Regina Margherita Children's Hospital; Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Raffaldi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Infectious Diseases Unit; University of Turin; Regina Margherita Children's Hospital; Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Barbui","sequence":"additional","affiliation":[{"name":"Department of Microbiology; University of Turin; San Giovanni Battista Hospital; Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Luccoli","sequence":"additional","affiliation":[{"name":"Department of Pediatric Pulmonology; Regina Margherita Children's Hospital; Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier-Angelo","family":"Tovo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Infectious Diseases Unit; University of Turin; Regina Margherita Children's Hospital; Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,2,8]]},"reference":[{"key":"10.1002\/ppul.22755-BIB0001|ppul22755-cit-0001","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1345\/aph.18146","article-title":"Clinical use of fluoroquinolones in children","volume":"34","author":"Alghasham","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1002\/ppul.22755-BIB0002|ppul22755-cit-0002","first-page":"301","article-title":"Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs: worldwide, 2000-2004","volume":"55","author":"Centers for Diseases Control and Prevention","year":"2006","journal-title":"MMWR"},{"key":"10.1002\/ppul.22755-BIB0003|ppul22755-cit-0003","volume-title":"Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency update 2008","author":"World Health Organization","year":"2008"},{"key":"10.1002\/ppul.22755-BIB0004|ppul22755-cit-0004","unstructured":"Istituto Superiore di Sanit\u00e0 Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute. Tubercolosi. Available at htpp:\/\/www.epicentro.iss.it\/problemi\/Tubercolosi\/Tb_Mdr-Xdr.asp"},{"key":"10.1002\/ppul.22755-BIB0005|ppul22755-cit-0005","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/jac\/dkq091","article-title":"Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data","volume":"65","author":"Angeby","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/ppul.22755-BIB0006|ppul22755-cit-0006","first-page":"128","article-title":"Gatifloxacin for TB (OFLOTUB) study team. A phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis","volume":"12","author":"Rustomjee","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1002\/ppul.22755-BIB0007|ppul22755-cit-0007","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2165\/00003495-200767140-00007","article-title":"Fluoroquinolones for the treatment of pulmonary tuberculosis","volume":"67","author":"Moadebi","year":"2007","journal-title":"Drugs"},{"key":"10.1002\/ppul.22755-BIB0008|ppul22755-cit-0008","first-page":"1","article-title":"Fluoroquinolones for treating tuberculosis","volume":"23","author":"Ziganshina","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1002\/ppul.22755-BIB0009|ppul22755-cit-0009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.prrv.2010.09.010","article-title":"Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians","volume":"12","author":"Schaaf","year":"2011","journal-title":"Paediatr Respir Rev"},{"key":"10.1002\/ppul.22755-BIB0010|ppul22755-cit-0010","volume-title":"Guidance for national tuberculosis programmes on the management of tuberculosis in children","author":"World Health Organization","year":"2006"},{"key":"10.1002\/ppul.22755-BIB0011|ppul22755-cit-0011","volume-title":"Rapid advice. Treatment of tuberculosis in children","author":"World Health Organization","year":"2010"},{"key":"10.1002\/ppul.22755-BIB0012|ppul22755-cit-0012","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tube.2011.11.001","article-title":"Paediatric use of second-line anti-tuberculosis agents: a review","volume":"92","author":"Seddon","year":"2012","journal-title":"Tuberculosis"},{"key":"10.1002\/ppul.22755-BIB0013|ppul22755-cit-0013","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MOP.0b013e32835357c3","article-title":"Pediatric tuberculosis: new guidelines and recommendations","volume":"24","author":"Perez-Velez","year":"2012","journal-title":"Curr Op Pediatr"},{"key":"10.1002\/ppul.22755-BIB0014|ppul22755-cit-0014","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(09)60333-0","article-title":"Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial","volume":"373","author":"Conde","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/ppul.22755-BIB0015|ppul22755-cit-0015","first-page":"605","article-title":"Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis","volume":"10","author":"Johnson","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1002\/ppul.22755-BIB0016|ppul22755-cit-0016","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0378-4274(77)90016-9","article-title":"Arthropathy induced by antibacterial fused N-Alkyl-4-pyridone-3-carboxylic acids","volume":"1","author":"Ingham","year":"1977","journal-title":"Toxicol Lett"},{"key":"10.1002\/ppul.22755-BIB0017|ppul22755-cit-0017","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1086\/516119","article-title":"Quinolone arthropathy in animals versus children","volume":"25","author":"Burkhardt","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1002\/ppul.22755-BIB0018|ppul22755-cit-0018","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1542\/peds.2006-1722","article-title":"The use of systemic fluoroquinolones","volume":"118","author":"Committee on Infectious Diseases","year":"2006","journal-title":"Pediatrics"},{"key":"10.1002\/ppul.22755-BIB0019|ppul22755-cit-0019","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.mop.0000192520.48411.fa","article-title":"The use of fluoroquinolones in children","volume":"18","author":"Leibovitz","year":"2006","journal-title":"Curr Opin Pediatr"},{"key":"10.1002\/ppul.22755-BIB0020|ppul22755-cit-0020","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/INF.0b013e318269cc6a","article-title":"Treatment of tuberculosis with levofloxacin or moxifloxacin: report of six pediatric cases","volume":"31","author":"Chauny","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/ppul.22755-BIB0021|ppul22755-cit-0021","doi-asserted-by":"crossref","first-page":"e1253","DOI":"10.1542\/peds.2009-2172","article-title":"Two pediatric cases of multidrug-resistant tuberculosis treated with linezolid and moxifloxacin","volume":"126","author":"Pinon","year":"2010","journal-title":"Pediatrics"},{"key":"10.1002\/ppul.22755-BIB0022|ppul22755-cit-0022","first-page":"672","article-title":"Management of drug-resistant tuberculosis","volume":"14","author":"Chiang","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1002\/ppul.22755-BIB0023|ppul22755-cit-0023","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/INF.0b013e31820b583d","article-title":"Drug-resistant tuberculosis. Pediatric guidelines","volume":"30","author":"Al-Dabbagh","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/ppul.22755-BIB0024|ppul22755-cit-0024","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/AAC.40.7.1610","article-title":"In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis","volume":"40","author":"Rastogi","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/ppul.22755-BIB0025|ppul22755-cit-0025","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/jac\/dki376","article-title":"Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis","volume":"56","author":"Gillespie","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/ppul.22755-BIB0026|ppul22755-cit-0026","unstructured":"Clinicaltrials, gov Controlled comparison of two moxifloxacin containing treatment shortening regimens in pulmonary tuberculosis (REMoxTB). March 2009. Available at http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00864383?term=moxifloxacin&rank=1"},{"key":"10.1002\/ppul.22755-BIB0027|ppul22755-cit-0027","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1086\/653115","article-title":"Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis","volume":"51","author":"Jacobson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1002\/ppul.22755-BIB0028|ppul22755-cit-0028","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/00365540701849931","article-title":"Severe acute polyarthritis in a child after high doses of moxifloxacin","volume":"40","author":"Torres","year":"2008","journal-title":"Scand J Infect Dis"}],"container-title":["Pediatric Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fppul.22755","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/ppul.22755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T03:33:50Z","timestamp":1644291230000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ppul.22755"}},"subtitle":["Moxifloxacin for Pediatric Pulmonary Tuberculosis"],"short-title":[],"issued":{"date-parts":[[2013,2,8]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"URL":"https:\/\/doi.org\/10.1002\/ppul.22755","relation":{},"ISSN":["8755-6863"],"issn-type":[{"value":"8755-6863","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2,8]]}}}